Table 6 |
|||||||
|
The pvdhfr/pvdhps genotypes and therapeutic responses of 15 patients from Tsiroanomandidy (Madagascar, 2006) treated with sulphadoxine-pyrimethamine for P. vivax infections |
|||||||
|
Sequence polymorphism in |
|||||||
|
Patient |
pvdhfr |
Pvdhps |
No. of mutations in the 2 genes |
Therapeutic responseb |
|||
|
|
|||||||
|
Trial no. |
Age (Years) |
33 |
58 |
117 |
383 |
||
|
|
|||||||
|
VIV7 |
2 |
P |
S |
S |
A |
0 |
ACPR |
|
60446 |
2.5 |
P |
S |
S |
A |
0 |
ACPR |
|
VIV14 |
7 |
L |
S |
S |
A |
1 |
ACPR |
|
VIV18 |
13 |
P |
S |
S |
A |
0 |
ACPR |
|
60756 |
42 |
P |
S |
S |
A |
0 |
ACPR |
|
VIV3 |
12 |
P |
R |
N |
G |
3 |
ACPR |
|
VIV8 |
34 |
P |
S |
N |
A |
1 |
ACPR |
|
VIV20 |
9 |
P |
R |
N |
A |
2 |
TF |
|
62298 |
5 |
P |
R |
N |
A |
2 |
ACPR |
|
60250 |
6 |
P |
R |
N |
A |
2 |
ACPR |
|
60149 |
8 |
P |
R |
N |
G |
3 |
ACPR |
|
VIV4 |
30 |
P |
R |
N |
G |
3 |
ACPR |
|
VIV12 |
6 |
P |
R |
N |
G |
3 |
TF |
|
62079 |
0.8 |
P |
R |
N |
A |
2 |
TF |
|
VIV15 |
2 |
P |
R |
N |
A |
2 |
Reinfection or relapse |
|
|
|||||||
|
Barnadas et al. Malaria Journal 2008 7:35 doi:10.1186/1475-2875-7-35 |
|||||||